Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315946095> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- W2315946095 abstract "Background Patients with rheumatoid arthritis (RA) are more likely to develop chronic kidney disease (CKD) than those without it over time [1]. CKD is one of the major limiting factors for the use of RA-related drugs [2], and has some influence on the clinical course of RA. Objectives To evaluate the impact of CKD on the treatment and complications of Japanese patients with RA. Methods We enrolled 300 Japanese patients with RA (245 females and 55 males; mean age 61.6±13.7 years; disease duration 11.1±9.6 years) at 4 hospitals from April 2011 to September 2011. Renal function was evaluated by the estimated glomerular filtration rate (eGFR) calculated from the Cockcroft-Gault formula modified for Japanese patients. These patients were divided into two groups by their eGFR: group A, eGFR≥60 ml/min/m2, which represents normal renal function to CKD stage G1-2, and group B, eGFR Results Group B consisted of 47 patients (15.7%). Patients in group B were significantly older (70.1±9.4 vs. 60.0±13.8 years), with longer duration of RA (14.3±10.1 vs. 10.6±9.4 years), and higher prevalence of hypertension (51.1% vs. 17.0%). The frequency of use of NSAIDs (14.9% vs. 32.0%) and dose of MTX (3.4±3.6 vs. 4.8±3.6 mg) were significantly lower in group B, but there were no differences in the frequency or dose of corticosteroid, frequency of DMARDs including MTX, or total biologics used. The prevalence of severe infectious events was significantly higher in group B than group A (25.0% vs. 10.6%). There were no significant differences between these 2 groups in disease activity or other complications. On the other hand, patients treated with biologics (biologics group) tended to have a higher prevalence of infectious events than those without them (17.6% vs. 10.4%; p=0.076). In the biologics group, in particular, patients in group B had a significantly higher prevalence of infections than those in group A (41.2% vs. 13.2%). Multivariable analysis revealed CKD to be one of the independent risk factors for infectious events in patients with biologics (β=-1.526, p=0.041). Conclusions RA patients with CKD were older and had a longer duration of RA than those without CKD. They were administrated a lower dose of MTX, but disease activity was almost the same. They had a higher prevalence of infections, and CKD was one of the independent risk factors especially in those with biologics. Therefore, we need to pay particular attention to infections in RA patients with CKD, especially those treated with biologics. References LaTonya J. Hickson et al. Am J Kidney Dis. 2013 Oct 4. Epub ahead of print. Axel J Hueber et al. Ann Rheum Dis. 2007;66:981-2. Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.3584" @default.
- W2315946095 created "2016-06-24" @default.
- W2315946095 creator A5014169394 @default.
- W2315946095 creator A5015289084 @default.
- W2315946095 creator A5043628933 @default.
- W2315946095 creator A5045000185 @default.
- W2315946095 creator A5047345235 @default.
- W2315946095 creator A5050771781 @default.
- W2315946095 creator A5072013505 @default.
- W2315946095 date "2014-06-01" @default.
- W2315946095 modified "2023-09-27" @default.
- W2315946095 title "FRI0096 Impact of Chronic Kidney Disease on the Treatment and Complications of Japanese Patients with Rheumatoid Arthritis" @default.
- W2315946095 doi "https://doi.org/10.1136/annrheumdis-2014-eular.3584" @default.
- W2315946095 hasPublicationYear "2014" @default.
- W2315946095 type Work @default.
- W2315946095 sameAs 2315946095 @default.
- W2315946095 citedByCount "0" @default.
- W2315946095 crossrefType "journal-article" @default.
- W2315946095 hasAuthorship W2315946095A5014169394 @default.
- W2315946095 hasAuthorship W2315946095A5015289084 @default.
- W2315946095 hasAuthorship W2315946095A5043628933 @default.
- W2315946095 hasAuthorship W2315946095A5045000185 @default.
- W2315946095 hasAuthorship W2315946095A5047345235 @default.
- W2315946095 hasAuthorship W2315946095A5050771781 @default.
- W2315946095 hasAuthorship W2315946095A5072013505 @default.
- W2315946095 hasConcept C126322002 @default.
- W2315946095 hasConcept C159641895 @default.
- W2315946095 hasConcept C2777575956 @default.
- W2315946095 hasConcept C2778653478 @default.
- W2315946095 hasConcept C71924100 @default.
- W2315946095 hasConcept C90924648 @default.
- W2315946095 hasConceptScore W2315946095C126322002 @default.
- W2315946095 hasConceptScore W2315946095C159641895 @default.
- W2315946095 hasConceptScore W2315946095C2777575956 @default.
- W2315946095 hasConceptScore W2315946095C2778653478 @default.
- W2315946095 hasConceptScore W2315946095C71924100 @default.
- W2315946095 hasConceptScore W2315946095C90924648 @default.
- W2315946095 hasLocation W23159460951 @default.
- W2315946095 hasOpenAccess W2315946095 @default.
- W2315946095 hasPrimaryLocation W23159460951 @default.
- W2315946095 isParatext "false" @default.
- W2315946095 isRetracted "false" @default.
- W2315946095 magId "2315946095" @default.
- W2315946095 workType "article" @default.